{{vm.title}}
25{{vm.includesText}}
{{item}}
{{vm.selectText}}
{{ vm.welcomeLabel.trim() }},
{{ vm.userName }}
{{ vm.text }}
{{vm.newUser1}} {{vm.newUser2}} {{vm.newUser3}} {{vm.newUser4}}
{{ vm.unknownUser }}
{{ vm.title }}
{{ vm.title }}
{{ vm.title }}
- {{ vm.siteSelectorList.flyout.cell1.heading }} {{ site.countryLocale }} {{ vm.siteSelectorList.flyout.cell1.global.countryLocale }}
{{ vm.closeTabLabel }}
- {{ vm.flyout.cell2.title }} {{ vm.flyout.cell2.newTabAllow }} {{ vm.flyout.cell2.title }}
- {{ vm.flyout.cell3.title }} {{ vm.flyout.cell3.newTabAllow }} {{ vm.flyout.cell3.title }}
- {{ vm.flyout.cell1.viewAll.label }} {{ vm.flyout.cell1.viewAll.newTabAllow }} {{ vm.flyout.cell1.viewAll.label }}
Healthcare and Life Sciences CFO Insights
CFO Insights
CFOs are leading the path for transformation.
CFOs are leading the path for transformation
-
Opportunities in an evolving market
Opportunities in an evolving market
2019 Health Care & Life Sciences Investment Outlook
2019 Health Care & Life Sciences Investment Outlook
-
On the 2019 healthcare board agenda
On the 2019 healthcare board agenda
Board and audit committee agendas should continue to evolve in 2019 amid the game-changing implications of technology, consolidation, and new entrants.
Board and audit committee agendas should continue to evolve in 2019 amid the game-changing implications of technology, consolidation, and new entrants.
-
Revenue for the life sciences industry:
Revenue for the life sciences industry:
New standard. New challenges.
New standard. New challenges.
THE CFO AGENDA
With a shift from volume to value, decreased margins, and portfolio rationalization, healthcare and life sciences CFOs must navigate a sea of change. Learn how KPMG can assist CFOs improve operational effectiveness, implement strategic plans, drive profitable growth, and instate a governance model.
Connect with us
- Find office locations kpmg.findOfficeLocations
- Email us kpmg.emailUs
- Social media @ KPMG kpmg.socialMedia
Want to do business with KPMG?
